SecBot SecBot
SECBOTREPLAY Home › Report › SYRE

SYRE · Spyre Therapeutics' shelf registration (Form S-3) has become effective,…

Spyre Therapeutics, Inc. · EFFECT filed Mar 2, 2026 at 00:15 ET

At the news

NEUTRALIMPACT 3/10

EFFECT filed Mar 2, 2026 at 00:15 ET

Spyre Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to issue unspecified securities from time to time. This is a routine capital markets update with no immediate financial impact.

  • Form EFFECT filed for Spyre Therapeutics, Inc. (SYRE)
  • Effectiveness date: February 27, 2026
  • Underlying registration is Form S-3 (shelf registration)
  • No specific offering size, pricing, or securities type disclosed

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access